EGFR and metastatic colorectal cancer: Although tumour growth in responsive patients may be closely linked to an increase in EGFR/CEP7 ratio, the literature in other tumour entities, especially in metastatic colorectal cancer demonstrates the experimental difficulties in finding a valid cut-off [19].